Literature DB >> 1500166

Lymphokine-activated killer cell regulation of T-cell-mediated immunity to Candida albicans.

S Wei1, D K Blanchard, S McMillen, J Y Djeu.   

Abstract

Monocytes are important accessory cells in the activation of T cells for specific antigen recognition yet little is known of their regulation. We demonstrated here that interleukin-2 (IL-2)-induced human lymphokine-activated killer (LAK) cells can inhibit monocyte antigen presentation, depending on the state of differentiation of the monocytes. Adherent monocytes cultured for 4 days in medium or granulocyte-macrophage colony-stimulating factor (GM-CSF) were found to equally process and present intact Candida albicans to autologous Percoll gradient-isolated T cells, as measured by [3H]thymidine uptake. However, only the GM-CSF-cultured monocytes were functionally inhibited by autologous 4-day IL-2-induced LAK cells. Even soluble candidal cell wall mannoprotein antigens could not be presented by these monocytes after exposure to LAK cells. Pretreatment of these monocytes with LAK cells for 1 h, followed by subsequent removal of the nonadherent LAK cells, was sufficient to cause significant inhibition, with maximal inhibition observed after 4 h. Northern (RNA) blot analysis indicated that mRNA expression for IL-1 alpha and IL-1 beta in response to C. albicans stimulation was also down-regulated in GM-CSF-cultured monocytes exposed to LAK cells. Interestingly, freshly isolated, Percoll gradient-purified large granular lymphocytes did not suppress antigen presentation in GM-CSF-treated monocytes. Another important finding was the inability of LAK cells to suppress the ability of freshly isolated or gamma interferon-cultured monocytes, which are resistant to LAK cell-mediated lysis, to present antigen to T cells. In contrast, IL-3 was similar to GM-CSF in inducing LAK cell susceptibility in monocytes. Taken together, these results indicated that IL-2 can induce LAK cells to down-regulate antigen presentation function in a select set of monocytes that have been activated by colony-stimulating factor (GM-CSF and IL-3) but not by gamma interferon. LAK cells may therefore play an important role in regulation of monocytes and their function, depending on their differentiation state.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500166      PMCID: PMC257365          DOI: 10.1128/iai.60.9.3586-3595.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  The basis for the immunoregulatory role of macrophages and other accessory cells.

Authors:  E R Unanue; P M Allen
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

Review 2.  The costimulatory function of antigen-presenting cells.

Authors:  C T Weaver; E R Unanue
Journal:  Immunol Today       Date:  1990-02

3.  The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.

Authors:  L L Lanier; A M Le; C I Civin; M R Loken; J H Phillips
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.

Authors:  D K Blanchard; M B Michelini-Norris; C A Pearson; S McMillen; J Y Djeu
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

6.  The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies.

Authors:  B Perussia; G Trinchieri; A Jackson; N L Warner; J Faust; H Rumpold; D Kraft; L L Lanier
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

7.  Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism.

Authors:  G Trinchieri; D Granato; B Perussia
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

8.  Suppression of human monocyte function against Candida albicans by autologous IL-2-induced lymphokine-activated killer cells.

Authors:  S Wei; D Serbousek; S McMillen; D K Blanchard; J Y Djeu
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

9.  Interferon decreases the growth inhibition of Mycobacterium avium-intracellulare complex by fresh human monocytes but not by culture-derived macrophages.

Authors:  D K Blanchard; M B Michelini-Norris; J Y Djeu
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

10.  Clinical effects and toxicity of interleukin-2 in patients with cancer.

Authors:  M T Lotze; Y L Matory; A A Rayner; S E Ettinghausen; J T Vetto; C A Seipp; S A Rosenberg
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

View more
  2 in total

Review 1.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

2.  Effect of abrogation of natural killer cell activity on the course of candidiasis induced by intraperitoneal administration and gastrointestinal candidiasis in mice with severe combined immunodeficiency.

Authors:  R A Greenfield; V L Abrams; D L Crawford; T L Kuhls
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.